Showing results (121-130 of 216) with videos related to
Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2012
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphomaBenjamin Kasenda, Vanessa Haug, Elisabeth Schorb, et al.Clinical Nuclear Medicine|February 29, 2020
FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot StudyCansu Özden, Lars Frings, Ivayla Apostolova, et al.Neuroimage. Clinical|February 12, 2019
Hypercapnic BOLD MRI compared to H<sub>2</sub><sup>15</sup>O PET/CT for the hemodynamic evaluation of patients with Moyamoya DiseaseTill-Karsten Hauser, Achim Seeger, Benjamin Bender, et al.Synapse (New York, N.Y.)|July 2, 2015
Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiographyStefanie Geisler, Nicola Beindorff, Markus Cremer, et al.EJNMMI Research|April 17, 2024
Short post-injection seizure duration is associated with reduced power of ictal brain perfusion SPECT to lateralize the seizure onset zoneAmir Karimzadeh, Kian Baradaran-Salimi, Berthold Voges, et al.Neuroradiology|September 27, 2021
Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [<sup>15</sup>O]water PETLeonie Zerweck, Constantin Roder, Till-Karsten Hauser, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 15, 2014
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility resultsAngelika Bilger, Martin-Immanuel Bittner, Anca-L Grosu, et al.Epilepsia|June 8, 2017
Reduced glucose metabolism in neocortical network nodes remote from hypothalamic hamartomas reflects cognitive impairmentKathrin Wagner, Andreas Schulze-Bonhage, Horst Urbach, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
Kidney Doses in <sup>177</sup>Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?Michael Mix, Tobias Renaud, Felix Kind, et al.The Journal of Clinical Endocrinology and Metabolism|May 21, 2026
68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional ImagingJulia G Fricke, Katharina Laubner, Manuela Schildmeijer, et al.Pageof 22